Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05969080 · ClinicalTrials.gov registry record · NA
Self-Injury Treatment and Recovery in Veterans
A NA study of Self Injurious Behavior, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05969080: Recruiting NA study of Self Injurious Behavior, sponsored by VA Office of Research and Development.
NCT05969080 is a NA study of Self Injurious Behavior that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 40 participants, below the 105-participant average among 13 other Self Injurious Behavior trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05969080, a NA study of Self Injurious Behavior, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times higher than the general population. Moreover, NSSI is associated with increased risk for violence, psychiatric distress, and marked impairment in psychosocial functioning. Even though NSSI is distinct from suicidal behaviors in several important ways, NSSI remains a strong predictor of a future suicide attempt. The primary goal of this project is to evaluate the treatment and acceptability of a brief intervention for NSSI that aims to reduce psychosocial impairment and NSSI behaviors in Veterans.
Primary Outcome
All participants (N = 40) will need to be enrolled by the end of the second year of the study to consider the recruitment benchmark met.
Conditions Studied
Interventions
- BEHAVIORAL Treatment for Self-Injurious Behaviors
- OTHER Treatment As Usual
Study Locations (1)
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT05969080 shows while recruiting
NCT05969080 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 105-participant average among 13 other Self Injurious Behavior trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Self Injurious Behavior appearing as the primary indexed condition, and to 2 interventions - of which Treatment for Self-Injurious Behaviors is the first listed.
NCT05969080 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05969080 about?
NCT05969080 is a clinical study titled "Self-Injury Treatment and Recovery in Veterans". Nonsuicidal self-injury (NSSI) refers to the intentional destruction of one's own body tissue without suicidal intent and for purposes that are not socially sanctioned. While NSSI has been understudied among Veterans, the lifetime prevalence rate of NSSI in Veterans is approximately three times high...
What is the current status of trial NCT05969080?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-10-15. Estimated completion is 2027-03-31.
What conditions does trial NCT05969080 study?
This clinical trial studies the following conditions: Self Injurious Behavior.
What interventions are being tested in trial NCT05969080?
The interventions under investigation include: Treatment for Self-Injurious Behaviors (BEHAVIORAL), Treatment As Usual (OTHER).
Who is sponsoring clinical trial NCT05969080?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05969080 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Self Injurious Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05969080's enrollment target sits among peer trials
40 8th of 13 higher than 6 of 13 other Self Injurious Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Self Injurious Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Harnessing Communication Preferences
RECRUITING · NA
-
Youth Empowerment and Safety Intervention
RECRUITING · NA
-
Therapeutic Evaluative Conditioning to Reduce Adolescents' Self-injurious Thoughts and Behaviors During and After Psychiatric Inpatient Hospitalization
RECRUITING · NA
-
A Clinical Trial for Self-Injurious Behavior
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI